GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Cyclically Adjusted Revenue per Share

Raia Drogasil (BSP:RADL3) Cyclically Adjusted Revenue per Share : R$17.66 (As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Raia Drogasil's adjusted revenue per share for the three months ended in Mar. 2025 was R$6.076. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$17.66 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Raia Drogasil's average Cyclically Adjusted Revenue Growth Rate was 15.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 17.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 18.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Raia Drogasil was 18.90% per year. The lowest was 13.50% per year. And the median was 18.00% per year.

As of today (2025-06-23), Raia Drogasil's current stock price is R$14.00. Raia Drogasil's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was R$17.66. Raia Drogasil's Cyclically Adjusted PS Ratio of today is 0.79.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Raia Drogasil was 3.18. The lowest was 0.79. And the median was 2.10.


Raia Drogasil Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Raia Drogasil's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Cyclically Adjusted Revenue per Share Chart

Raia Drogasil Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.74 10.63 12.52 14.69 17.13

Raia Drogasil Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.30 15.88 16.44 17.13 17.66

Competitive Comparison of Raia Drogasil's Cyclically Adjusted Revenue per Share

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Cyclically Adjusted PS Ratio falls into.


;
;

Raia Drogasil Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Raia Drogasil's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=6.076/168.1016*168.1016
=6.076

Current CPI (Mar. 2025) = 168.1016.

Raia Drogasil Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.000 100.006 0.000
201509 0.000 101.392 0.000
201512 5.196 104.247 8.379
201603 1.468 106.979 2.307
201606 1.625 108.851 2.510
201609 1.694 109.986 2.589
201612 1.784 110.802 2.707
201703 3.562 111.869 5.352
201706 1.887 112.115 2.829
201709 3.983 112.777 5.937
201712 2.042 114.068 3.009
201803 2.003 114.868 2.931
201806 2.109 117.038 3.029
201809 2.193 117.881 3.127
201812 2.334 118.340 3.315
201903 2.308 120.124 3.230
201906 2.466 120.977 3.427
201909 2.685 121.292 3.721
201912 2.791 123.436 3.801
202003 2.888 124.092 3.912
202006 2.606 123.557 3.546
202009 2.961 125.095 3.979
202012 3.235 129.012 4.215
202103 3.249 131.660 4.148
202106 3.405 133.871 4.276
202109 3.581 137.913 4.365
202112 3.762 141.992 4.454
202203 3.789 146.537 4.347
202206 4.331 149.784 4.861
202209 4.526 147.800 5.148
202212 4.749 150.207 5.315
202303 4.714 153.352 5.167
202306 5.041 154.519 5.484
202309 5.138 155.464 5.556
202312 6.135 157.148 6.563
202403 5.457 159.372 5.756
202406 5.648 161.052 5.895
202409 6.021 162.342 6.235
202412 6.116 164.740 6.241
202503 6.076 168.102 6.076

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Raia Drogasil  (BSP:RADL3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Raia Drogasil's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=14.00/17.66
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Raia Drogasil was 3.18. The lowest was 0.79. And the median was 2.10.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Raia Drogasil Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company is engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines. Its brands include Impulso, Amplimed, HealthBit, Stix, 4Bio, Drogasil, Raia and others.

Raia Drogasil Headlines

No Headlines